Showing results (191-200 of 454) with videos related to

Sort By:
Pageof 46
Journal of Immunology (Baltimore, Md. : 1950)|October 19, 2012
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigenBree Foley, Sarah Cooley, Michael R Verneris, et al.
Materials Today (Kidlington, England)|October 6, 2018
Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromoleculesAnna Liu, Muhymin Islam, Nicholas Stone, et al.
Cell Death & Disease|February 16, 2018
Microfluidic cell sorting by stiffness to examine heterogenic responses of cancer cells to chemotherapyMuhymin Islam, Roman Mezencev, Brynn McFarland, et al.
Blood|April 18, 1998
Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitorsC Bomberger, M Singh-Jairam, G Rodey, et al.
Plos One|April 29, 2016
Incorporating Anthropogenic Influences into Fire Probability Models: Effects of Human Activity and Climate Change on Fire Activity in CaliforniaMichael L Mann, Enric Batllori, Max A Moritz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenograftsR B Wilder, J K McGann, W R Sutherland, et al.
American Journal of Obstetrics and Gynecology|February 1, 1994
Are obese women at higher risk for producing malformed offspring?D K Waller, J L Mills, J L Simpson, et al.
Blood|May 9, 2001
Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantationE K Waller, H Rosenthal, T W Jones, et al.
Leukemia & Lymphoma|October 31, 2006
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphomaSagar Lonial, Martha Arellano, Donald Hutcherson, et al.
Frontiers in Immunology|October 3, 2022
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host diseaseElizabeth Stenger, Cynthia R Giver, Amelia Langston, et al.
Pageof 46